About this episode
In Australia, peanut allergy affects around 3% of the population. Because there is no cure, those with a peanut allergy must adhere to strict avoidance, which can affect quality of life.
The good news is we now understand a lot more about trying to prevent food allergies developing, and much research is underway looking at possible treatments, including oral immunotherapy.
In this episode, we speak with lead researcher, Professor Mimi Tang, from Melbourne’s Murdoch Children’s Research Institute to discuss the findings their latest trial - comparing responses to peanut oral immunotherapy, both with and without the addition of a probiotic.
About today’s guest
Professor Tang is a Paediatric immunologist allergist at the Royal Children’s Hospital, Melbourne, Group Leader of Allergy Immunology Research at the Murdoch Children’s Research Institute and a Professor in the Department of Paediatrics at the University of Melbourne.
Her research programme is focused on developing novel therapies for food allergies that induce disease remission.
Professor Tang has received national and international awards recognising her achievements in allergy immunology research and clinical care and is regularly invited to speak at major international scientific meetings in the field.
She sits on various expert committees of the American Academy of Allergy Asthma and Immunology, World Allergy Organisation, Asia Pacific Association of Allergy Asthma and Clinical Immunology and the Australasian Society of Clinical Immunology and Allergy.
Supporting resources
Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(22)00006-2/fulltext
Sign up to NutENews
Follow us on Instagram, Twitter, Facebook and LinkedIn
CreditsHost: Belinda Neville
Contact us
